[go: up one dir, main page]

WO2007131999A1 - Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp - Google Patents

Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp Download PDF

Info

Publication number
WO2007131999A1
WO2007131999A1 PCT/EP2007/054687 EP2007054687W WO2007131999A1 WO 2007131999 A1 WO2007131999 A1 WO 2007131999A1 EP 2007054687 W EP2007054687 W EP 2007054687W WO 2007131999 A1 WO2007131999 A1 WO 2007131999A1
Authority
WO
WIPO (PCT)
Prior art keywords
lid
defined area
pcr
multiwell plate
capture molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/054687
Other languages
English (en)
Inventor
José REMACLE
Isabelle Alexandre
Martin Seippel
Sven Buelow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eppendorf Array Technologies SA
Original Assignee
Eppendorf Array Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06114104A external-priority patent/EP1788096A1/fr
Application filed by Eppendorf Array Technologies SA filed Critical Eppendorf Array Technologies SA
Priority to EP07729139A priority Critical patent/EP2035142B1/fr
Priority to US12/301,190 priority patent/US20090186401A1/en
Priority to AT07729139T priority patent/ATE525132T1/de
Publication of WO2007131999A1 publication Critical patent/WO2007131999A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50853—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates with covers or lids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/046—Function or devices integrated in the closure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0636—Integrated biosensor, microarrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0829—Multi-well plates; Microtitration plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50851—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates specially adapted for heating or cooling samples

Definitions

  • the present invention proposes a simple and effective lid being part of a device having multiwells for performing simultaneous amplifications by PCR and detections of multiple target molecules on unlabeled capture molecules immobilized on the lid.
  • the invention also proposes such a lid carrying capture molecules to perform the detection and quantification of multiple nucleotide molecules in a real-time PCR amplification.
  • Detection and quantification of an organism, or a part of it such as a gene is best performed using the molecular amplification of the nucleotide sequence followed by its detection. Amplification of a given sequence is performed by several methods such as the polymerase chain reaction (PCR) (U.S. Pat. Nos. 4,683,195 and 4,683,202), ligase chain reaction (LCR) (Wu and Wallace, Genomics, Vol. 4, p.560, 1989) or the Cycling Probe Reaction (CPR) (U.S. Pat. No. 5,011,769) which are the most common.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • CPR Cycling Probe Reaction
  • PCR is the most commonly used method of amplification. PCR uses two oligonucleotide primers, an agent for polymerization, a target nucleic acid template. The successive cycles of denaturation of nucleic acid, annealing and extension of the primers produce large number of copies of a particular nucleic acid segment. Segments of genomic DNA can be amplified up to 10 million fold with very high specificity and fidelity when using optimized conditions.
  • the PCR are usually performed in a single tubes and in wells being part of a 96-wells or 384 well plate format and are thereafter analyzed for the presence of the amplified sequence known as amplicons.
  • One particular way to detect the presence of a given target nucleic acid sequence, and thus of a particular organism, is to monitor the appearance of amplicons during the PCR cycles.
  • the method is called real time PCR.
  • the method gives the possibility of quantifying the amplified sequence as the cycles progress, and to calculate the amount of the sequence in the original sample.
  • the method uses a homogeneous format, and the PCR and the detection are performed within one tube. Performing both amplification and detection in a closed chamber lowers the contamination risk caused by opening the tubes in conventional post-PCR detection methods.
  • One way to assay for the presence of the amplicons is to take advantage of certain intercalating dyes, the fluorescence of which increases, or changes its parameters, when the dye is intercalated into double stranded DNA.
  • One to the most commonly used dye is SYBR green.
  • the method assays for the amount of double stranded DNA, mainly the amplicons present in the solution.
  • U.S. Pat. No. 4,683,195 and U.S. Pat. No. 6,171,785 also use the introduction of detectable DNA binding agents (such as ethidium bromide) into the amplification reaction, which agents produce a detectable signal in the PCR solution that is enhanced upon binding double-stranded DNA.
  • beacons are structurally similar to the tradition single strand hybridization probe except that the ends of the beacon contain equal length self-complementary segments, which, in the free state, will bond to each other forming a loop terminated by a blunt end stem.
  • the ends of the stem have a fluorescer attached to one side and a quencher attached to the other side, so that it is self quenching in the unbound state.
  • the fluorophor and quencher become separated in space allowing the sample to fluoresce.
  • the TaqMan probes are among the most popular specific methods of detection in real time and are commercially available.
  • the TaqMan probe contains both a fluorescer and a quencher in close proximity to one another which inhibits fluorescence in the probe hybridized to the target amplicon or in excess probes in solution.
  • the fluorochrome is released from the vicinity of the quencher by the digestion of the probes during the copying of the amplicon strand by the Taq polymerase having a 5 '-3' exonuclease activity. They provide a detectable molecule that accumulates in the solution during the successive cycles.
  • 5,716,784 provides an alternative method based on the use of two complementary probes, a first, analytical probe being labeled at its 5' terminus with an energy transfer donor fluorophore, and a second, detection probe being labeled at its 3' terminus with an energy transfer acceptor fluorophore.
  • Quantitative detection of oligonucleotide analytical probe hybridized in solution to the oligonucleotide detection probe provides a measure of the amount of oligonucleotide analytical probe used up in the amplification of the target nucleic acid sequence and thus provides a measure of amount of target nucleic acid sequence amplified in the PCR replication procedure.
  • the quantitative detection of the analytical probe involves spectrophotometrical energy transfer detection in solution.
  • U.S. Pat. No. 5,928,907 describes an apparatus for monitoring the formation of a nucleic acid amplification reaction product in real time that uses an optic fiber focused in the volume of the sample.
  • the fluorescence is usually detected in the solution trough the tip or the bottom of the tubes or the wells.
  • WO 04/101733 discloses a wash- free PCR amplification tube for direct gene detection.
  • a molecular beacon is immobilized inside the reaction tube that is designed for the PCR purpose.
  • the PCR tube also comprises a transparent window at the section where the molecular beacon is fixed inside the PCR tube.
  • the immobilized probe comprises a fluorescer and a quencher.
  • the quencher is positioned at the free end of the probe.
  • the quencher is released from the vicinity of the fluorescer by the digestion of the immobilized probes during the copying of the amplicon strand by the Taq polymerase having a 5 '-3' exonuclease activity. They provide a detectable molecule that accumulates on the support during the successive cycles.
  • the present invention aims to provide a device for a method that has the advantages of the real time PCR methods described here above using specific probes for the detection, but that overcomes the limitations of single (or very few) detection per assay and/or the complexity of the design of labeled probes having both specificity and physico-chemical constraints such as quenching or FRET.
  • the present invention aims to overcome most of the above mentioned limitations by proposing a simple and effective lid being part of a device having multiwells for performing simultaneous amplifications by PCR and detections of multiple target molecules on unlabeled capture molecules immobilized on the lid.
  • the invention relates to a sealable lid (1) for a PCR multiwell plate (2) provided with at least one defined area (3), said defined area being configured to be mated to at least one well (4) of the multiwell plate (2), at least one of said defined area (3) being pretreated to be provided with unlabeled capture molecule (5).
  • the lid allows real-time PCR to be performed both in parallel assays and in multi- detections per assay.
  • the sealable lid (1) is also provided with at least one defined area (3), said defined area being configured to be mated to at least four wells (4) of the multiwell plate (2), at least one of said defined area (3) being pretreated to be provided with unlabeled capture molecule (5).
  • One feature of the invention is that the capture molecules are not taking part in the PCR reaction and thus do not interfere with the PCR happening in the solution.
  • Figure 1 is a general schematic representation of a preferred sealable lid (1) according to the invention, comprising a plurality of defined areas (3), each defined area corresponding to at least one well (4) of the multiwell plate (2) on which it can be mated by a sealable material (9).
  • Figure 2a is a general schematic representation of a preferred sealable lid (1) being configured to be mated to a multiwell plate by means of a sealable material (9).
  • Figure 2b shows a detailed top view of a defined area (3) carrying immobilized capture molecules (5).
  • Figure 2c shows another embodiment for the defined area (3) being divided in four compartments (6), each compartment carrying different capture molecules (5, 5', 5", 5'").
  • Figure 2d shows an alternative embodiment for the defined area (3) carrying capture molecules being immobilized according to a micro-array (7) in specifically localized areas (8).
  • Figure 3 is a general schematic representation of a preferred sealable lid (1) according to the invention, comprising a plurality of defined areas (3), each defined area corresponding to at least four wells (4) of the multiwell plate (2) on which it can be mated by a sealable material (9). This lid is preferably used for end point measurement of PCR product. After the PCR, the multiwell plate (2) is flipped and the content of four wells comprising four different PCR products is contacted with one defined area (3) carrying immobilized capture molecules (5).
  • Figure 4 Results for the end point measurement of SNP (single nucleotide polymorphism) in PCR products using a preferred lid of the invention as provided in figure 3.
  • Three PCR were performed in individual tubes of a 96-wells plate using cy3 labeled primers. Each tube contained a different SNP of the CYP2C9 gene: mutation 3 of exon 7, mutation 10 and corresponding wild type sequence of exon 5 and the corresponding primer pairs.
  • a lid comprising a defined area having fixed upon its surface a microarray was fixed on the top of the three PCR tubes by means of an adaptor.
  • the microarray contained the different capture molecules specific of the three amplicons (2C9*3 for mutation 3 of exon 7; 2C9*l,10 for wild type sequence of exon 5 and 2C9*10 for mutation 10 of exon 5).
  • the multiwell plate was flipped back, centrifuged to remove the PCR solution from the lid and the micro-array was read in fluorescence using a confocal scanner.
  • the result shows signals on the specific capture molecules 2C9*3, 2C9*l,10 and 2C9*10 as expected.
  • nucleic acid oligonucleotide
  • array oligonucleotide
  • probe target nucleic acid
  • binding substantially “hybridising specifically to”, “background”, and “quantifying” are as described in the international patent application WO97/27317, incorporated herein by reference.
  • nucleotide triphosphate As described in the document WO00/72018, incorporated herein by references.
  • the terms “Homologous sequences” and “consensus sequence” are described in the European patent application WOO 1/77372, incorporated herein by reference.
  • the term “homology” is intended to mean the degree of identity of one polynucleotide sequence to another polynucleotide sequence. There may be complete homology (i.e. 100% identity) between two or more polynucleotides. The degree of homology is calculated after alignment of the sequence and may be determined by any method well known to a person skilled in the art.
  • capture molecule refers to a molecule, or complex or combination of molecules, that is capable of specifically binding to one target molecule, or to a family of target molecules, or to one or more member (s) of a plurality of target molecules, or portion(s) thereof.
  • the capture molecules are preferably nucleic acids, which are either synthesized chemically in situ on the surface of the support or synthesized ex situ and subsequently affixed to the support. Nucleic acid binding is achieved via base pairing between two polynucleotides, one being the immobilized capture molecule and the other one the target to be detected.
  • Capture molecules also comprise derivatives of the nucleic acid, such as PNA or LNA, as long as they can bind specifically the target polynucleotide molecule.
  • single capture molecule species is a composition of related polynucleotides for the detection of a given sequence by base pairing hybridization or by molecular recognition between polypeptides or proteins. Polynucleotides are synthesized either chemically or enzymatically, or isolated from samples, but the synthesis or isolation is not always perfect and the capture molecule is contaminated with other related molecules, like shorter polynucleotides.
  • the essential characteristic of one capture species for the invention is that the overall species can be used for capture of a given target nucleotide molecule.
  • polynucleotide sequences that are complementary to one or more genes or to the genome sequence refers to polynucleotides that are capable of hybridizing under stringent conditions to at least part of the nucleotide sequence of said genes or genome or copy thereof.
  • Polynucleotides also include oligonucleotides (comprising more than 2 bases but fewer than 100 bases), which can be used under particular conditions.
  • Such hybridizable polynucleotides will typically exhibit at least about 75% sequence identity at the nucleotide level to said genes or genome, preferably about 80% or 95% sequence identity or preferably more than 95% nucleotide sequence identity to said genes or genome.
  • Micro-array means a support on which multiple capture molecules are immobilized in order to be able to bind to the given specific target molecule.
  • the micro-array is preferentially composed of capture molecules present at specifically localized areas on the surface or within the support or on the substrate covering the support.
  • a specifically localized area is the area of the surface that contains bound capture molecules specific for a determined target molecule.
  • the specific localized area is either known from the method that was used in building the micro-array, or is defined during or after the detection.
  • a spot is the area where specific target molecules are fixed on their capture molecules and seen by the detector.
  • the micro-array may also contain detection controls which are labeled. These controls check the performance of the detection and circumvent the array, but they are not used to detect specific target molecules.
  • micro-arrays of capture molecules are also provided on different supports, as long as the different supports contain specific capture molecules and may be distinguished from each other in order to be able to quantify the specific target molecules. This can be achieved by using a mixture of beads having particular features and being able to be distinguished from each other in order to quantify the bound molecules.
  • One bead or a population of beads is then considered as a spot having a capture molecule specific of one target molecule.
  • the "amplicon” of the invention means target nucleotide molecules being the result of PCR amplification of a nucleotide molecule present in a biological material.
  • "Intermittent contact” means to be physically in contact or not according to some time frame.
  • the PCR solution is in intermittent contact with the capture molecule, means the PCR solution is moved or displaced from the surface having fixed the capture molecules for a given time period (non contact) and then it is moved back to its original position (contact).
  • Preferably more than 95% and preferably more than 99% of the PCR solution is moved or displaced in the reaction chamber.
  • the PCR solution is preferably displaced by gravity drain resulting from a change in orientation of the reaction chamber, preferably rotation, translation, or lateral movement of the reaction chamber.
  • the lid of the invention is specifically designed to perform an end point measurement of PCR product or a real-time measurement of the PCR after being sealed on a multiwell plate.
  • the lid comprises at least one defined area that is pretreated to be provided with capture molecules or having capture molecules immobilized by a consumer depending on his requirement. Home made immobilization is performed on pretreated lid for the fixation of the desired capture molecules.
  • the capture molecules are specifically designed for the detection of amplified target nucleotide molecules.
  • the lid contains at least 2, preferably at least 6, more preferably at least 24, still more preferably at least 96 defined areas.
  • the multiwell plate comprises preferably at least 2, preferably at least 8, more preferably at least 24, still more preferably at least 96, even more preferably at least 384 wells. Wells are separated from each other by a pitch of 4.5, or a multiple thereof, such as 9 mm.
  • the multiwell plate is a preferred format for performing different PCR assays in parallel. Multiplexing is obtained by using different wells carrying different PCR products that are contacted with different defined areas of the lid carrying one or more capture molecule(s). The number of capture molecules per defined area can be adapted according to the consumer requirement.
  • the defined area of the lid has fixed upon its surface at least 4 different capture molecules that are physically separated in compartments.
  • the defined area of the lid has fixed upon its surface a micro-array comprising at least 5 different capture molecules being immobilized in specifically localized areas of said defined area.
  • the micro-array comprises more than 10 different capture molecules, preferably more than 20 capture molecules, more preferably more than 50 capture molecules.
  • different defined areas of the same lid have fixed the same capture molecules.
  • capture molecules are polynucleotides used to detect target nucleotide molecules that are labeled during the PCR.
  • the capture molecules preferably have an amplicon-specific binding sequence (capture portion), and a spacer portion bound to the chamber surface.
  • the immobilized capture molecule is preferably a polynucleotide having an amplicon-specific binding sequence, and a spacer portion of at least 20 nucleotides, preferably at least 50, more preferably more than 90 nucleotides.
  • the measurement of the amplified target nucleotide molecules is performed on the lid of the multiwell plate after hybridization on capture molecules.
  • the lid is not removed for the detection and there is no washing before the measurement.
  • the assay of amplification and detection is performed in a closed well of the multiwell plate. Washing is avoided since it would include liquid handling of the solution containing amplified target and may entail possible contamination of further assays.
  • the measurement of the bound labeled amplicons is performed in the absence of liquid.
  • the absence of liquid is obtained by gravity drain, such as resulting from changing the orientation of the reaction chamber.
  • changing the orientation of the reaction chamber by a method selected from the group consisting of: rotation, translation, flipping or lateral movement of the reaction chamber.
  • One defined area of the lid is exactly aligned with one well or with more than one well depending on the application.
  • the lid is used for real-time PCR measurement.
  • the measurement of the target bound to the lid is repeated during at least two thermal cycles, preferably during the annealing temperature step of the cycle.
  • the detection is performed in each of the PCR cycles.
  • fluorescent dyes there is no requirement for different fluorescent dyes to quantify different nucleotide molecules.
  • One fluorescent dye is sufficient for the quantification of multiple different target nucleotide molecules since they are individualized on the defined area of the lid because of their specific binding by hybridization on capture molecules being specific of each target nucleotide sequence and being localized in distinct areas of the defined area of the lid (compartment or spot of a micro-array).
  • both amplicons will be labeled with the same fluorescent dye but they will be detected and/or quantified on separated capture molecules having a different position on the lid without the need of several fluorescent dyes as required in the real time PCR performed in solution.
  • the lid is used for end point PCR measurement.
  • the measurement is performed only at the end of the amplification.
  • one defined area of the lid corresponds to one or more wells.
  • each defined area corresponds to at least four wells of the multiwell plate. This is particularly advantageous in case of multiplex PCR.
  • the use of more than 5 primer pairs in a PCR well often decrease the efficiency of the amplification due to the formation of primer dimers and non-specific annealing of the primers.
  • the PCR can be split in different wells, each well having a limited number of primer pairs.
  • the PCR products are pooled and hybridized on the same capture molecules being present on a single defined area of the lid. This embodiment is performed at best by flipping the multiwell plate in order to pool the content of the separated wells and contacting the mix with one defined area of the lid for hybridization.
  • the specificity can still be increased further by the use of different capture molecules for the same target nucleotide molecule.
  • Two or more capture molecules can be designed to bind the same strand or one capture molecule may be provided to bind the sense strand of the amplified product and another capture molecule the antisense strand.
  • the nucleotide molecules to be amplified are homologous nucleotide sequences that are quantified on micro-array during the PCR using consensus primers as described in WOO 177372.
  • the same primers are used to amplify all the homologous sequences which are possibly present in a sample.
  • the amplicons are discriminated on different capture molecules, each one targeting a different homologous sequence. So with only one primer pair and one fluorescent dye, the assay is made multiplex by the use of consensus primers for the PCR and multiple capture molecules present on the micro-array for their detection.
  • the capture molecules are attached preferably by covalent link in the defined area of the lid.
  • the capture molecules are terminated by a primary amino group and are covalently fixed on the defined area having fixed upon their surface aldehyde groups.
  • Such reaction does not require any coupling agent and results in the formation of imine covalent link.
  • This link can be further stabilized into amine function by a reducing agent preferably in the presence of a solution OfNaBH 4 .
  • Deposition of the capture molecules on the lid can be performed by a company upon request or by the consumer himself.
  • Deposition of the capture molecules by the consumer is preferentially done by pipetting the capture molecules solutions in different compartments of the main defined area. In a preferred embodiment, the defined area is divided in at least 4 compartments.
  • Deposition of the capture molecule in the form of a micro-array is preferentially done with physical means such as plain pin or split pin or "pin and ring" having a physical contact with the surface, or by release of a micro-droplet of solution by methods such as piezo or nanodispenser.
  • in situ synthesis of capture molecules is performed on the support using light directed chemical synthesis for the synthesis of oligonucleotides or polynucleotides in known locations such as provided by US patents 5,744,305 and 6,346,413.
  • the lid surface is activated in order to provide reactive groups for the fixation of capture molecules.
  • the pretreated lid preferentially bears aldehyde, epoxide or N-hydroxymaleimide or any chemical group on which a capture molecule will react by chemical reaction with such as but not limited to free amino or sulfhydryl groups.
  • Pretreated lids have the same embodiments as described here above.
  • the lid comprises or is made of a material selected from the group consisting of glass, metal, polymer (preferably thermo -resistant having low self- fluorescence) or any other material used in the micro-array technology (preferably activated glass bearing aldehyde or epoxide or acrylate groups), said lid optionally further comprising also specific coatings, markers or devices (bar codes, electronic devices, etc.) for improving the assay.
  • glass presents many advantages (like being inert and having a low self- fluorescence), other supports such as polymers, with various chemically well-defined groups at their surface, allowing the binding of the nucleotide sequences are useful.
  • the support bearing the capture molecules has a 3 dimensional porous structure.
  • Conventional glass slides have less than 60% silicon dioxide on their surface. This inherently limits the amount of chemical bonding available on the surface. Porous material exhibits an increased loading capacity of capture molecules.
  • Typical porous supports include gel pads, fused-fiber matrix and fibrous polymer matrix.
  • the capture molecules can be immobilized entirely in the porous material, or on a layer of porous material mounted on top of a flat surface such as glass, plastic, or metal.
  • polymers are becoming increasingly used as support for micro-array and for the miniaturisation of the biological assays due to the development of the microfluidic technology and the "lab on a chip" concept.
  • the polymer material of the lid is selected from the group consisting of: polycarbonate (PC), polyethylene (PE), Cycloolefin copolymer (COC), cyclic olefin polymer (COP) or a mixture thereof.
  • PC polycarbonate
  • PE polyethylene
  • COC Cycloolefin copolymer
  • COP cyclic olefin polymer
  • a preferred COP product is Zeonex® because of its excellent optical properties, chemical resistance, thermal stability and low fluorescence (http://www.zeonchemicals.com).
  • the defined area of the lid is configured to be mated to at least one well of a multiwell plate by means of a sealable material.
  • the sealable material is preferably made of a soft polymer or a glue which surrounds each defined area in order to assure a perfect sealing to the corresponding well of the multiwell plate.
  • the defined area is configured to be mated to at least one well of the multiwell plate by using an adaptor comprising a sealable material.
  • the adaptor is preferably made of a soft polymer which is placed between the lid and the multiwell plate and assures a perfect sealing between a defined area of the lid and the corresponding well of the multiwell plate. If necessary, pressure can be applied to the lid to obtain a sealing with the multiwell plate.
  • the surface of a defined area of the lid bearing the capture molecule is maintained flat at temperature higher than 85°C, preferably higher than 95°C.
  • the hybridized amplicons have to be detected by a detector and preferably the different localized area that contain different capture molecules and present in a defined area have to show the same signal intensity if bound with the same amount of targets.
  • a defined area of the lid has a flatness tolerance of less than 100 microns preferably of less than 25 microns.
  • the lid is thermo-resistant and is maintained flat at temperature higher than 85°C.
  • the light transmittance of the lid at the wavelength used for the detection is higher than 80% and even higher than 90%.
  • the signal detected trough the window resulting from the binding of the amplicons to the immobilized capture molecules is at least 2 times, preferably at least 5 times, more preferably at least 10 times higher than the signal obtained in the absence of amplicons or in conditions in which no binding can take place.
  • the polynucleotides being used as capture molecule are between 10 and 1000 nucleotide long and preferably between 100 and 400 nucleotides long.
  • the polynucleotide capture molecules contain a spacer portion according to the patent
  • the polynucleotides that are used as capture molecules are present on the micro-array localized area at a density superior to 10 fmoles per cm 2 , and preferably more than 100 fmoles per cm 2 surface of the solid support.
  • the micro-array according to this invention contains between 4 and 100000 spots per cm 2 and preferably between 20 and 1000 spots per cm 2 . Each spot is preferably the localized area for one capture molecule. Miniaturization allows performing one assay upon a large number of surface spots (usually circular spots of about 0.1 to about 1 mm diameter). A low density array, containing 20 to 400 spots is easily obtained at low cost with pins of between 0.2 and 0.4 mm of diameter. Higher density of spots up to 1,600 spots per cm2 can be obtained by reducing the size of the spots for example between 0.1 mm and 0.2 mm diameter. Methods for obtaining capture molecules of higher density have been described earlier as in US 5,445,934.
  • Miniaturization of the spot size allows for a high number of data to be obtained and analyzed simultaneously, the possibility to perform replicates and with only a small amount of biological sample being necessary for the assay.
  • Miniaturization for detection on micro-arrays is preferably associated with microfluidic substrate for separation, extraction of nucleotide molecules from a cell extract.
  • the localized area is comprised between about 10 ⁇ m 2 and about 1 mm 2 and preferably between about 1 ⁇ m 2 and about 100 ⁇ m 2 .
  • the capture molecules present on the lid are complementary to at least one part of the sequence of an amplified target nucleotide sequence present in solution.
  • the capture molecules comprise a nucleotide sequence that is able to specifically bind the amplified target nucleotide sequence, said specific nucleotide sequence (capture portion) is also preferably separated from the surface of the solid support by a spacer arm (spacer portion) of at least about 6.8 nm or 20 nucleotides in a double stranded form, and which has no binding affinity for the amplified target molecule.
  • the capture molecule is a single stranded polynucleotide containing a capture portion able to specifically bind the labeled target nucleotide molecule and a spacer portion of at least 20 nucleotides and preferably more than 90 nucleotides.
  • the spacer portion can be either single or double stranded DNA.
  • the capture portion of the capture molecule is comprised between 15 and 100 nucleotides and more preferably between 15 and 35 nucleotides.
  • Detectable labels suitable for use in the present invention include any composition detectable by electromagnetic light emission.
  • the target molecules are labeled with a fluorescent dye.
  • the fluorescent label is preferably incorporated into the target by enzymatic or chemical reaction. Typical enzyme reaction includes the incorporation of nucleotide analogues into the target. Alternatively, primers labeled at their 5' end with a fluorescent dye are incorporated into the target. Fluorochromes are also incorporated into the targets by chemical reaction such as the reaction of fluorescent dye bearing a N- hydroxysuccinimide (NHS) group with amines groups of the targets.
  • Useful fluorescent dyes in the present invention include Cyanine dyes (Cy 3, Cy 5, Cy7), Fluorescein, Texas red,
  • the excitation wavelength for Cyanin 3 is comprised between 540 and 558 nm with a peak at 550 nm and the emission wavelength is comprised between 562 and 580 nm with a peak at 570 nm.
  • the excitation wavelength for Cyanin 5 is comprised between 639 and 659 nm with a peak at 649 nm and the emission wavelength is comprised between 665 and 685 nm with a peak at 670 nm.
  • the excitation wavelength for Cyanin 7 is comprised between 733 and 753 nm with a peak at 743 nm and the emission wavelength is comprised between 757 and 777 nm with a peak at 767 nm.
  • Patents teaching the use of such labels include U.S. Patent Nos. 3,817,837; 3,850,752; 3,939,350; 3,996,345; 4,277,437; 4,275,149; and 4,366,241.
  • the fluorescent dye is Cyanin 3, Cyanin 5 or Cyanin 7.
  • the original nucleotide molecule is not necessary labeled in the sample but should lead to amplified labeled target molecules during the amplification step.
  • the amplified nucleotide molecules are able to hybridize on the capture molecules after a denaturation step.
  • the amplified nucleotide molecules are double stranded, in theory they should reassociate in solution much faster than they hybridise on capture molecules fixed on a solid support where diffusion is low and the specific binding sequence is short, thus reducing even more the rate of reaction. Therefore, it was unexpected to observe a significant signal increase on the capture molecules over multiple thermal cycles after a short period of incubation time.
  • the measurement is performed on bound target labeled molecules present on the lid while they reassociate in a double stranded form in the solution during annealing and/or elongation of the thermal cycle.
  • the length of the amplified target nucleotide molecules are selected as being of a limited length preferably between 100 and 2000 bases, preferably between 200 and 1500 bases, and still more preferably between 300 and 800 bases.
  • This preferred requirement depends on the possibility to find primers to amplify the required sequences possibly present in the sample. Too long target may reallocate faster and adopt secondary structures which may inhibit the fixation on the capture molecules.
  • the thermal cycler is adapted to fit the support format of a 96 wells multiwell plate. The alternative heating and cooling is preferably obtained using a Peltier element or pulsed air.
  • the light beam is a laser beam which is focused on the surface of the lid defined area in order to excite directly the fluorescent molecules.
  • the laser beam is preferably focused perpendicular to the surface of the lid.
  • the emitted light is detected in the opposite direction of the excitation laser beam.
  • the emitted light is preferably detected as a confocal light and measured after amplification by a photomultiplier.
  • the surface of the lid defined area is scanned by the laser beam in order to obtain a maximum light excitation of the bound targets.
  • the signal associated with a capture molecule on the lid defined area is quantified.
  • the preferred method is the scanning of the array(s) with a scanner which is preferably a laser confocal scanner for the detection of fluorescent labeled targets.
  • the resolution of the image is comprised between 1 and 500 ⁇ m and preferably between 5 and 50 ⁇ m.
  • the lid defined area is preferably scanned and each localized area of the micro-array or each compartment is subsequently measured.
  • the scanning of the array is performed within 1 min, more preferably within 30 sec and still more preferably within 10 sec. If reading is repeated over multiple thermal cycles, the scan of each localized area preferably is measured at the same precise moment of a temperature step.
  • a subsequent measurement of different defined areas of the lid can be advantageously used to monitor a kinetic of hybridization of a labeled target nucleotide molecule on the same capture molecule which has been immobilized at different defined areas of the support and which are scanned in a time dependent manner.
  • the data on the quantification of the amplified target molecules performed at different PCR cycles are processed in order to quantify the amount of nucleotide molecule present in the original solution before the amplification.
  • the amplification cycles lead to the doubling of the target sequence in each cycle when the efficiency of the amplification is maximal.
  • Quantification of the original nucleotide concentration is calculated from the extrapolation of the first cycle that gives a detectable value or from a value crossing a fixed threshold. The concentration is then calculated from a reference curve or from the data obtained on a standard molecule.
  • the data are processed in order to obtain a signal value for each of the localized area.
  • the data are processed in order to obtain a signal value for each of the localized area and for the local background. The data are further processed by subtracting the background from the signal value for each of the localized area.
  • the quantification of the amount of nucleotide molecule is performed by comparing the signal value of the localized area with a fixed value.
  • the quantification of the amount of nucleotide molecule is performed by comparing the number of thermal cycles necessary to reach a fixed value (cycle threshold or CT) with the CT of a reference nucleotide molecule.
  • the reference nucleotide molecule is preferably amplified in the same solution and detected on the same micro-array as the target nucleotide molecule.
  • the quantification of the amount of nucleotide molecule is performed by comparing the number of thermal cycles necessary to reach a fixed value (CT) with a standard curve wherein the CTs are plotted against standard concentrations.
  • a lid in Zeonex® having 96 defined areas sealable on a 96-wells plate (as provided in figure 1) was functionalized for the presence of aldehyde groups according to the following protocol.
  • a lid in Zeonex® having 96 defined areas sealable on a 96-wells plate was functionalized for the presence of aldehydes according to the method described in example 1.
  • Aminated DNA was then spotted according to a micro-array in the defined areas of the lid derivatized with aldehyde groups.
  • the aminated capture molecules were spotted from solutions at concentrations of 3 ⁇ M.
  • the capture molecules were printed onto the wells using split pins (n° 1545 Genetix Limited).
  • the defined areas of the lid were washed once for 1 min with 0.2% SDS, twice with distilled water.
  • the defined areas were then incubated for 5 min with NaBH 4 solution (2.5 mg/ml of PBS 75%/ Ethanol 25%), washed twice with distilled water and dried.
  • the lid was stored under vacuum at 4°C.
  • Example 3 End point measurement of SNP in PCR products using a lid carrying a micro-array Three PCR were performed in individual wells of a 96-well plate using cy3 labeled primers. The first PCR was performed on a plasmid containing the sequence of the exon 7 from CYP2C9 gene which containing the mutation 3. The second PCR well was performed on a plasmid containing the exon 5 from CYP 2 C9 gene which had the sequence for the wild type corresponding to the mutation 10. The third PCR well was performed on a plasmid containing the exon 5 from CYP2C9 gene which had the sequence containing the mutation 10. All wells contained the primer pairs for the amplification of the sequences.
  • Capture molecule immobilization in a defined area of a lid [00102] The Diaglass slides (Eppendorf, Hamburg, Germany) were functionalized for the presence of aldehydes according to the method described in patent application WO02/18288. The protocol described in this patent application was followed for the grafting of aminated DNA to a defined area of the aldehyde derivatized glass slide. The aminated capture molecules were spotted from solutions at concentrations of 3 ⁇ M. The capture molecules were printed onto microscopic glass slides with a home made robotic device using 250 ⁇ m diameter pins. The spots were 400 ⁇ m in diameter and the volume dispensed was about 0.5 nanolitre. Slides were dried at room temperature and stored at 4 0 C until used.
  • the capture portion of the capture molecules used in this experiment had the fo Ho wing sequences :
  • the mutated base is underlined as compared to the wild type sequence.
  • Each capture molecule comprised a spacer portion of 90 bases long at the 5' end of the capture portion, said spacer portion having the following sequence:
  • the CYP2C9 gene contains mutations in the exons 5 and 7.
  • the DNA template for the PCR is a plasmidic DNA obtained by cloning the entire exon 5 in vector pGEMT Easy and exon 7 in vector pCR4 Topo. They were amplified by PCR using the following primers. [00119] Primer pair 1, for exon 5
  • MP2C906 (SEQ ID NO: 6):
  • MP2C902 (SEQ ID NO: 7):
  • MP2C903 (SEQ ID NO: 8):
  • MP2C904 (SEQ ID NO: 9):
  • the amplicon resulting from the amplification with primer pair 1 was specific of capture molecules SEQ ID NO: 3 or 4.
  • the amplicon resulting from the amplification with primer pair 2 was specific of capture molecules SEQ ID NO: 1 or 2.
  • the PCR were performed in individual tubes (200 ⁇ l) of a 96-wells plate on plasmidic DNA in a final volume of 50 ⁇ l.
  • the PCR mixture was the following: Ix concentrated Topo Buffer, dNTP mix (each of dNTP at a final concentration of 200 ⁇ M), 0.25 ⁇ M of primer MP2C902 Cy3 labelled at 5' end (SEQ ID NO: 7), 0.125 ⁇ M of MP2C906 (SEQ ID NO: 6), 0.25 ⁇ M of primer MP2C903 Cy3 labelled at 5' end (SEQ ID NO: 8), 0.125 ⁇ M of MP2C904 (SEQ ID NO: 9), Topo Taq DNA polymerase at 2.5U in 50 ⁇ l, potassium glutamate at 150 mM.
  • plasmidic DNA of exon 7 of CYP2C9 carrying the mutation 3.
  • plasmidic DNA corresponding to exon 5 (wild type of mutation 10) and (mutation 10) of CYP2C9 were substituted to the plasmidic DNA of exon 7.
  • the amplicon of tube 1 was supposed to react with capture molecule 2C9*3 (SEQ ID NO: 1), amplicon of tube 2 with capture molecule 2C9*l,10 (SEQ ID NO: 3) and amplicon of tube 3 with capture molecule 2C9* 10 (SEQ ID NO: 4).
  • a glass lid comprising a defined area having fixed upon its surface a microarray was fixed on the top of the three PCR tubes by means of an adaptor.
  • the PCR were performed in a thermocycler (Eppendorf, Hamburg, Germany). Samples were first denatured at 94 0 C for 5 min. Then 40 cycles of amplification were performed consisting of 30 sec at 94 0 C, 1 min at 63 0 C and 1 min at 72 0 C and a final extension step of 10 min at 72 0 C.
  • the multiwell plate was flipped and the content of three wells comprising three different PCR products (50 ⁇ l each) was contacted with the lid carrying immobilized capture molecules and incubated for 45 min at 60 0 C. After hybridization, the multiwell plate was flipped back, centrifuged for 1 min at 1440 rpm to remove the PCR solution from the lid and the micro-array was read in fluorescence using the Axon scanner
  • the scanner used as excitation light a laser which was focussed on the surface of the support.
  • the emission light was detected and amplified by a photomultiplier.
  • the scanned 16-bit images were imported to the software, 'Genepix 5" (Axon, Union city, Ca, USA) which was used to quantify the signal intensities.
  • the signal was quantified on four capture molecules present in three replicates on the array: 2C9*1,3 (SEQ ID NO: 2), 2C9*3 (SEQ ID NO: 1), 2C9*l,10 (SEQ ID NO: 3) and 2C9*10 (SEQ ID NO: 4).
  • the local background was subtracted and signal minus background was plotted against the capture molecules.
  • the arrays also contained a negative hybridization control (neg hyb ctl, SEQ ID NO: 5), and positive detection control labeled with Cy3 present in quadruplicate on the array.
  • the capture molecule used as negative hybridization control was silent.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un couvercle simple et efficace appartenant à un dispositif multi-cupules destiné à effectuer des amplifications simultanées par RCP et à détecter plusieurs molécules cibles parmi des molécules de capture non marquées immobilisées sur ledit couvercle.
PCT/EP2007/054687 2004-11-18 2007-05-15 Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp Ceased WO2007131999A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07729139A EP2035142B1 (fr) 2006-05-17 2007-05-15 Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp
US12/301,190 US20090186401A1 (en) 2004-11-18 2007-05-15 Lid for pcr vessel comprising probes permitting pcr amplification and detection of the pcr product by hybridisation without opening the pcr vessel
AT07729139T ATE525132T1 (de) 2006-05-17 2007-05-15 Deckel für ein pcr-gefäss mit proben, der pcr- amplifikation und den nachweis des pcr-produkts durch hybridisierung ohne öffnen des pcr-gefässes gestattet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114104A EP1788096A1 (fr) 2005-11-18 2006-05-17 Couvercle pour un tube de PCR comprenant des sondes permettant la réaction de PCR et la détection de l'amplificat par hybridation sans ouvrir ledit tube de PCR
EP06114104.0 2006-05-17

Publications (1)

Publication Number Publication Date
WO2007131999A1 true WO2007131999A1 (fr) 2007-11-22

Family

ID=38420642

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/054687 Ceased WO2007131999A1 (fr) 2004-11-18 2007-05-15 Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp

Country Status (3)

Country Link
EP (1) EP2035142B1 (fr)
AT (1) ATE525132T1 (fr)
WO (1) WO2007131999A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135674A1 (fr) * 2008-06-19 2009-12-23 Eppendorf Array Technologies SA Dispositif pour analyses multiparamétriques
US9777335B2 (en) 2001-06-04 2017-10-03 Geneohm Sciences Canada Inc. Method for the detection and identification of methicillin-resistant Staphylococcus aureus
EP4104929A1 (fr) * 2021-06-16 2022-12-21 Leica Microsystems CMS GmbH Ensemble microplaque pour une pluralité d'échantillons
US11834720B2 (en) 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012675A1 (fr) * 1998-08-27 2000-03-09 Xtrana Inc. Dispositif assurant a lui seul l'extraction, l'amplification et la detection d'acides nucleiques
WO2001027327A2 (fr) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Procede et appareil destines a produire un grand nombre de reactions au moyen d'une plaque matrice
WO2003022421A2 (fr) * 2001-09-07 2003-03-20 Corning Incorporated Ensemble de micro-colonnes sur plate-forme pour analyses a fort debit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012675A1 (fr) * 1998-08-27 2000-03-09 Xtrana Inc. Dispositif assurant a lui seul l'extraction, l'amplification et la detection d'acides nucleiques
WO2001027327A2 (fr) 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Procede et appareil destines a produire un grand nombre de reactions au moyen d'une plaque matrice
WO2003022421A2 (fr) * 2001-09-07 2003-03-20 Corning Incorporated Ensemble de micro-colonnes sur plate-forme pour analyses a fort debit

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777335B2 (en) 2001-06-04 2017-10-03 Geneohm Sciences Canada Inc. Method for the detection and identification of methicillin-resistant Staphylococcus aureus
US10577664B2 (en) 2001-06-04 2020-03-03 Geneohm Sciences Canada, Inc. Method for the detection and identification of methicillin-resistant Staphylococcus aureus
US10801074B2 (en) 2001-06-04 2020-10-13 Geneohm Sciences Canada, Inc. Method for the detection and identification of methicillin-resistant Staphylococcus aureus
US11834720B2 (en) 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
EP2135674A1 (fr) * 2008-06-19 2009-12-23 Eppendorf Array Technologies SA Dispositif pour analyses multiparamétriques
WO2009153348A3 (fr) * 2008-06-19 2010-03-18 Eppendorf Array Technologies S.A. Dispositif pour dosages à plusieurs paramètres
EP4104929A1 (fr) * 2021-06-16 2022-12-21 Leica Microsystems CMS GmbH Ensemble microplaque pour une pluralité d'échantillons

Also Published As

Publication number Publication date
EP2035142B1 (fr) 2011-09-21
ATE525132T1 (de) 2011-10-15
EP2035142A1 (fr) 2009-03-18

Similar Documents

Publication Publication Date Title
US20090186401A1 (en) Lid for pcr vessel comprising probes permitting pcr amplification and detection of the pcr product by hybridisation without opening the pcr vessel
US20090191618A1 (en) Reaction chamber for real time pcr comprising capture probes and permitting detection of the pcr product by hybridisation without opening the pcr vessel
WO2007131995A1 (fr) Chambre de réaction destinée à une rcp en temps réel comprenant des sondes de capture et permettant de détecter le produit rcp par hybridation, sans ouverture du contenant rcp
EP2041301B1 (fr) Identification et quantification d'une pluralité de (micro)organismes biologiques ou de leurs constituants
JP6226887B2 (ja) 多重デジタルｐｃｒ
EP2180066B1 (fr) Détection par génotypage du polymorphisme de nucléotides uniques via la plate-forme de microréseau du test invader en temps réel
JP2005537002A (ja) 新規な一体化したマイクロアレイ分析
AU742599B2 (en) Multiple functionalities within an array element and uses thereof
WO2008034896A2 (fr) Identification et quantification d'une pluralité de (micro)organismes biologiques ou de leurs composants
EP2035142B1 (fr) Couvercle destiné à un contenant rcp comprenant des sondes permettant une amplification rcp et une detection du product rcp par hybridation, sans ouverture du contenant rcp
US7829313B2 (en) Identification and quantification of a plurality of biological (micro)organisms or their components
US7875442B2 (en) Identification and quantification of a plurality of biological (micro)organisms or their components
EP1788097A1 (fr) Identification et quantification d'une pluralité d'acides nucléiques lors d'un essai homogène combinant une PCR en temps réel avec l'hybridation sur une puce oligonucléotidique
JP2007304094A (ja) 分析チップ
US20080026370A1 (en) Method For Geno-And Pathotyping Pseudomonas Aeruginosa
JP5145752B2 (ja) 分析チップ
JP5258755B2 (ja) 捕捉プローブを含み、ｐｃｒ槽を開けることなしにハイブリダイゼーションによるｐｃｒ産物の検出を可能にするリアルタイムｐｃｒ用反応チェンバ
AU2007251538A1 (en) Reaction chamber for real time PCR comprising capture probes and permitting detection of the PCR product by hybridisation without opening the PCR vessel
WO2010111776A1 (fr) Procédé et système destinés à l'amplification et à la quantification de multiples acides nucléiques
JP2009142175A (ja) 一塩基多型の検出方法及びプライマーセット

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07729139

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12301190

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007729139

Country of ref document: EP